AnythingResearch - Industry Analysis and Market Research Reports
Better Data, Better Decisions

2018 Market Analysis & Industry Outlook: In-Vitro Diagnostic Substance Manufacturing

Overview: the U.S. In-Vitro Diagnostic Substance Manufacturing Industry

This section provides answers to key questions about the industry:

  1. What is the total market size (industry revenue)?
  2. What is the industry outlook?
  3. Market Analysis: Is the market growing or declining, and how quickly?
  4. Are long-term forecasts positive or negative?
  5. What is the average company size in the industry?
  6. How many companies are in the industry?

Market Size & Industry Statistics

The total U.S. industry market size for In-Vitro Diagnostic Substance Manufacturing: Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders. In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.

Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.

market size 2018
Charts and graphs can be copied to Microsoft Word and Powerpoint presentations.

Statistics 2012        2013        2014        2015        2016        2017
Market Size
(Total Sales/Revenue)

Order at top of page
Total Firms
Total Employees
Average Revenue Per Firm
Average Employees Per Firm
Statistics Source: U.S. Census, AnythingResearch Market Analysis

Market Forecast

Market forecasts show the long term industry outlook and future growth trends. The following five-year demand forecast projects both short-term and long-term trends.

market forecast

Forecast / Industry Outlook 2017 2018 2019 2020 2021 2022
Market Forecast ($ millions)
Projected Industry Growth Rate (%)
Source: AnythingResearch Economic Analysis

Product & Services Breakdown

Research products and services in the In-Vitro Diagnostic Substance Manufacturing industry generating sales. Note that products are broken into categories with different levels of classification.

Product Description Sales ($ millions) Percent of Total Sales

Industry Total

In-Vitro Diagnostic Substances Manufacturing

In-Vitro Diagnostic Substances

Analytical Laboratory Instrument Manufacturing

Analytical And Scientific Instruments, Excluding Optical

Total Miscellaneous Receipts

Resales - Sales Of Products Bought And Sold Without Further Manufacture, Processing, Or Assembly

Miscellaneous Receipts, Including Receipts For Repair Work, Sales Of Scrap And Refuse.

U.S. Geographic Distribution: Revenue Statistics by State

Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.

U.S. map by state

In-Vitro Diagnostic Substance Manufacturing Industry Price Trends

Rise and fall in market prices are affectedd by supply, demand, and the cost of goods/services sold. Higher demand or COGS will put upward price pressure on prices. Higher competition among In-Vitro Diagnostic Substance Manufacturing companies will put a downward pressure on prices. The chart shows how prices are changing within the industry, month-to-month over the last three years.

example price index trendline

Income Statement (Average Financial Metrics)

Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.

Industry AveragePercent of Sales
(Industry Benchmark)
Total Revenue

Order at top of page
Operating Revenue
Cost of Goods Sold
Gross Profit

Operating Expenses
Pension, profit sharing plans, stock, annuity
Rent paid on business property
Charitable Contributions
Domestic production activities deduction
Compensation of officers
Salaries and wages
Employee benefit programs
Taxes and Licenses
Bad Debts
Other Operating Expenses
Total Operating Expenses
Operating Income
Non-Operating Income
EBIT (Earnings Before Interest and Taxes)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit
Source: AnythingResearch Analysis of U.S. federal statistics

Financial Ratio Analysis

Financial ratio information can be used to benchmark how a In-Vitro Diagnostic Substance Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.

Profitability & Valuation RatiosIndustry Average
Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the In-Vitro Diagnostic Substance Manufacturing industry is performing.
Profit Margin
Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues.
Return on Equity (ROE)
Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings).
Return on Assets (ROA)
Return on Assets (ROA) is net income relative to total assets. The market research on In-Vitro Diagnostic Substance Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets.

Liquidity RatiosIndustry Average
Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability.
Current Ratio
Measures a firm's ability to pay its debts over the next 12 months.
Quick Ratio (Acid Test)
Calculates liquid assets relative to liabilities, excluding inventories.

Efficiency Ratios - Key Performance IndicatorsIndustry Average
Measure how quickly products and services sell, and effectively collections policies are implemented.
Receivables Turnover Ratio
If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections.
Average Collection Period
Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover
Inventory Turnover
A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort.
Fixed-Asset Turnover
Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue.

Compensation & Salary Surveys for Employees

Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.

TitlePercent of WorkforceBottom Quartile Average (Median) SalaryUpper Quartile
Management Occupations 11%

Order at top of page
Chief Executives0%
General and Operations Managers2%
Business and Financial Operations Occupations 8%
Business Operations Specialists 7%
Architecture and Engineering Occupations 6%
Life, Physical, and Social Science Occupations 16%
Life Scientists 6%
Physical Scientists 6%
Chemists and Materials Scientists 5%
Chemists 5%
Office and Administrative Support Occupations 9%
Production Occupations 32%
Other Production Occupations 26%
Packaging and Filling Machine Operators and Tenders 8%
Packaging and Filling Machine Operators and Tenders 8%
Source: Bureau of Labor Statistics

In-Vitro Diagnostic Substance Manufacturing Industry Market Share [PREMIUM]

Largest companies in the industry and related industries, with private company revenue estimates.

CompanyAddressRevenue Estimate

Innovation News

  • Poc Medical Systems trademarks "BREASTAT" - computer application software for mobile phones and tablets - 03/02/2018
  • Poc Medical Systems patents Devices And Methods For Detection Of Biomarkers - 03/01/2018
  • Baebies raises $13 million in funding. - 02/06/2018
  • Alpha-Tec Systems patents Mucolytic Tablet For A Sample Collection Device - 02/01/2018
  • Avioq trademarks "DIAGNOSTICS FOR LIFE" - Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use - 01/16/2018
  • Avioq patents Methods For Simultaneous Determination Of Serological Profile And Estimation Of Duration Post Hiv Infection - 10/26/2017
  • Baebies trademarks "FINDER" - Medical apparatus and instrument for screening, diagnosing, and monitoring congenital disorders - 09/08/2017
  • Toma Biosciences raises $6 million in funding. - 09/29/2016
  • Rheonix raises $12 million in funding. - 10/09/2015

  • Top Innovators

    CompanyInnovation Score
    Alpha-Tec Systems19
    Toma Biosciences
    Utak Laboratories

    Additional companies, details and innovation scoring in the full report.

    Latest Industry News

    • Binding Site Now Offers Bordetella pertussis Antigens for IVD Manufacturing & Research Applications - San Diego, CA — Binding Site’s Immunologicals Group is pleased to announce the addition of three (3) new Bordetella pertussis (VZV) antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications. (01/17/2018)
    • Facing 21st Century Public Health Threats: Our Nation's Preparedness and Response Capabilities, Part I - The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), in particular, recognized the key role the Food and Drug Administration (FDA ... seeking to validate candidate multiplex in vitro diagnostic tests that could be used to ... (01/17/2018)
    • Worldwide Microfluidic Devices Market and is Expected to Reach $13.24 Billion and CAGR 19.7% By 2024 - and in-vitro diagnostic industry. Furthermore, increasing awareness regarding the importance of controlled drug delivery is likely to add fuel to the global microfluidic devices market growth. Get a sample report at ... (01/16/2018)
    • To boost array of health-focused staff, Siemens Healthineers hosts Jan. 18 job fair - Innovative solutions from Siemens Healthineers cover all major segments of the in vitro diagnostics industry, including lab automation/diagnostics IT, clinical chemistry, immunoassay, hematology, hemostasis, drug testing, plasma proteins and infectious ... (01/07/2018)
    • Genfit : Reaches a Critical Milestone towards the Development of a Non-Invasive In Vitro Diagnostic (IVD) Test for NASH - diabetologists and hepatologists to support their diagnosis including decision to treat a patient with an anti-NASH drug. As part of the industrial phase for the development of a new In Vitro Diagnostic (IVD) test, GENFIT intends to partner with a major ... (06/23/2017)
    • GENFIT Reaches a Critical Milestone towards the Development of a Non-Invasive In Vitro Diagnostic (IVD) Test for NASH - GENFIT Reaches a Critical Milestone towards the Development of a Non-Invasive ... to support their diagnosis including decision to treat a patient with an anti-NASH drug. As part of the industrial phase for the development of a new In Vitro Diagnostic ... (06/23/2017)
    • Report: Reforms needed to address medical diagnostic errors - Get the full story at our sister site, Drug Delivery Business News. […] A group of manufacturing services companies ... US Food and Drug Administration explains requirements for in vitro diagnostic manufacturers to register for premarket notification ... (09/22/2015)
    • DCGI planning guidance documents for regulating in-vitro diagnostic devices - The Drug Controller General of India (DCGI) is planning to make and issue guidance documents for regulation of in-vitro diagnostic devices and regents for grant of manufacturing licences by state licencing authority with a view to bring uniformity in the ... (11/16/2012)
    • Research and Markets: 2010 U.S. in-Vitro Diagnostic Substance Manufacturing Industry Report - DUBLIN--(BUSINESS WIRE)--Research and Markets ( has announced the addition of the "2010 U.S. In-Vitro Diagnostic Substance Manufacturing Industry Report" report to their offering. (07/26/2010)

    Government Contracts

    In 2016, the federal government spent a total of $184,699,470 on In-Vitro Diagnostic Substance Manufacturing. It has awarded 4,677 contracts to 256 companies, with an average value of $721,482 per company.   

    Top government vendors:

    CompanyFederal ContractsTotal Award Amount

    Segments classified within this market research report

    This industry market research report includes companies whose primary business is any of the following:
    Coagulation in-vitro diagnostic substances manufacturing, Microbiology, virology, and serology in-vitro diagnostic substances manufacturing, Enzyme and isoenzyme in-vitro diagnostic substances manufacturing, Blood glucose test kits manufacturing, Cytology and histology in-vitro diagnostic substances manufacturing, Blood derivative in-vitro diagnostic substances manufacturing, HIV test kits manufacturing, Viral in-vitro diagnostic test substances manufacturing, Pregnancy test kits manufacturing, Hematology in-vitro diagnostic substances manufacturing, Hormone in-vitro diagnostic substances manufacturing, Diagnostic substances, in-vitro, manufacturing, In-vitro diagnostic substances manufacturing, etc.

    Related Reports

    Can't find what you're looking for? We have over a thousand market research reports. Ask us and an analyst will help you find what you need.

    Industries Related to In-Vitro Diagnostic Substance Manufacturing

    In-Vitro Diagnostic Substance Manufacturing